Viewing Study NCT06458764



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06458764
Status: RECRUITING
Last Update Posted: 2024-06-14
First Post: 2024-06-06

Brief Title: Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy A Cross-Sectional Study
Sponsor: Candiolo Cancer Institute - IRCCS
Organization: Candiolo Cancer Institute - IRCCS

Study Overview

Official Title: SEXCHECK - Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy A Cross-Sectional Study
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SEXCHECK
Brief Summary: Primary objectives

To estimate Sexual Dysfunction SD incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy
To detect the presence of SD-related distress in the population as a determining factor in the maintenance of a good quality of life

Secondary objectives

To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens
Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None